Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $228.42 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $29.62 | 2 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $29.35 | 2 | $0 (2024) |
| Amgen Inc. | $28.99 | 2 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $27.95 | 2 | $0 (2021) |
| Antares Pharma, Inc. | $21.28 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $15.81 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $14.47 | 1 | $0 (2021) |
| Seqirus USA Inc | $14.12 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.09 | 1 | $0 (2022) |
| Esperion Therapeutics, Inc. | $12.59 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.29 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($16.29) |
| 2023 | $21.28 | 1 | Antares Pharma, Inc. ($21.28) |
| 2022 | $68.78 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($16.43) |
| 2021 | $122.07 | 9 | Amgen Inc. ($28.99) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Cardio-renal | ||||||
| 01/18/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 10/27/2022 | Seqirus USA Inc | Fluad Quadrivalent (Biological), FLUCELVAX QUADRIVALENT | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Vaccines | ||||||
| 10/11/2022 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $8.33 | General |
| Category: Diabetes | ||||||
| 07/26/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: PRIMARY CARE | ||||||
| 01/18/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Gastroenterology | ||||||
| 12/01/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Gastroenterology | ||||||
| 11/23/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardio-renal | ||||||
| 09/13/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 08/10/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/21/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/08/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Neuroscience | ||||||
| 03/24/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Neuroscience | ||||||
| 03/10/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: PRIMARY CARE | ||||||
| 02/17/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,004 | 5,463 | $234,946 | $59,476 |
| 2022 | 41 | 2,609 | 7,566 | $328,255 | $88,994 |
| 2021 | 46 | 2,538 | 6,591 | $333,310 | $92,405 |
| 2020 | 35 | 1,950 | 4,826 | $237,200 | $55,312 |
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 327 | 362 | $113,020 | $28,556 | 25.3% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 56 | 58 | $24,708 | $8,107 | 32.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 121 | 130 | $24,800 | $4,754 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 83 | $17,806 | $4,537 | 25.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 202 | 315 | $12,814 | $2,587 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $7,144 | $2,052 | 28.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 72 | 74 | $6,804 | $1,129 | 16.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 23 | 25 | $4,925 | $873.44 | 17.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 44 | 44 | $2,182 | $712.80 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 78 | $702.00 | $647.32 | 92.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 80 | 84 | $1,958 | $633.49 | 32.4% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 38 | 40 | $1,648 | $527.00 | 32.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 51 | 52 | $1,275 | $416.52 | 32.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 44 | 44 | $1,117 | $364.76 | 32.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 90 | 100 | $984.00 | $321.00 | 32.6% |
| 83874 | Myoglobin (muscle protein) level | Office | 2023 | 25 | 25 | $969.00 | $316.50 | 32.7% |
| 84484 | Troponin (protein) analysis, quantitative | Office | 2023 | 25 | 25 | $935.25 | $305.50 | 32.7% |
| 82553 | Creatine kinase (cardiac enzyme) level, mb fraction only | Office | 2023 | 25 | 25 | $866.25 | $283.00 | 32.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 143 | 678 | $1,281 | $247.39 | 19.3% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 12 | 12 | $1,144 | $222.31 | 19.4% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 13 | 13 | $1,213 | $219.53 | 18.1% |
| 85379 | Coagulation function measurement, d-dimer; quantitative | Office | 2023 | 21 | 21 | $641.34 | $209.58 | 32.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 27 | $1,302 | $209.30 | 16.1% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 15 | 1,495 | $493.35 | $168.97 | 34.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 63 | 69 | $465.75 | $151.80 | 32.6% |
About Grace Couch, FNP-C
Grace Couch, FNP-C is a Family healthcare provider based in Sumter, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2018. The National Provider Identifier (NPI) number assigned to this provider is 1821565334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Grace Couch, FNP-C has received a total of $228.42 in payments from pharmaceutical and medical device companies, with $16.29 received in 2024. These payments were reported across 16 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($228.42).
As a Medicare-enrolled provider, Couch has provided services to 9,101 Medicare beneficiaries, totaling 24,446 services with total Medicare billing of $296,186. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Sumter, SC
- Active Since 11/01/2018
- Last Updated 11/01/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1821565334
Products in Payments
- NURTEC ODT (Drug) $42.04
- XIFAXAN (Drug) $29.62
- Kerendia (Drug) $29.35
- Aimovig (Biological) $28.99
- NOCDURNA (Drug) $21.28
- BELSOMRA (Drug) $15.81
- ENTRESTO (Drug) $14.47
- Fluad Quadrivalent (Biological) $14.12
- NEXLETOL (Drug) $12.59
- RYBELSUS (Drug) $11.82
- CeQur Simplicity (Device) $8.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sumter
Mrs. Cheryl Ward, Msn, Fnp-Bc, MSN, FNP-BC
Family — Payments: $5,451
Margaret Britt, Aprn-C, APRN-C
Family — Payments: $3,661
Jennifer Weich, Fnp-C, FNP-C
Family — Payments: $2,225
Jamie Lucia
Family — Payments: $2,144
Ms. Tracie Morris, Fnp, FNP
Family — Payments: $1,953
Brett Lynam, Aprn, APRN
Family — Payments: $1,910